A life insurance policy does not automatically form part of the estate, but this rule does not settle every issue between the beneficiary and the heirs. If you discover that the deceased named someone other than the legal heirs, a very specific question may arise: does that sum remain outside the succession even if high premiums were paid? And what happens if those payments reduced the share reserved for the spouse or children?
I want to help you separate three levels that are often confused: the beneficiary's right to the insurance payout, the premiums paid by the policyholder, and the protection of reserved heirs—that is, those individuals to whom the law reserves a portion of the estate. We will also see why the commercial name of the product is not enough: before applying life insurance rules, we must determine what contract was actually concluded.
The insurance payout generally goes to the beneficiary, not the heirs
The designated beneficiary acquires an independent right against the insurance company. Article 1920 of the Civil Code provides that the designation may be made in the contract, by a subsequent written declaration communicated to the insurer, or by will. If the insured person dies and the designation is effective, the company must pay the benefit to the indicated beneficiary.
This means that the insured sum generally is not divided according to inheritance shares. The beneficiary may also be a third party outside the succession, while an heir may not be a beneficiary. The source of their right is the insurance contract, not the acceptance of the inheritance. This framework is contained in Articles 1920 and 1923 of the Civil Code published on Normattiva.
The designation, however, must be read with precision. It is not equivalent to name an individual, indicate multiple parties in different percentages, or use the generic formula “my heirs.” In the latter case, it is necessary to establish who falls within the designation at the time of the insured event and what distribution criteria the contract provides. Therefore, knowing that a policy exists is not enough: the beneficiary clause, any modifications, and the documentation communicating them to the company matter.
The capital may instead assume a different hereditary relevance if it had already been collected by the policyholder prior to death, for example through the surrender of the policy. In this hypothesis, the discussion is no longer about the benefit owed by the insurer to a third-party beneficiary; rather, it is money that entered the deceased's assets and, if still existing, is destined to follow the ordinary rules of succession.
Why paid premiums can be relevant for heirs
The delicate point concerns the premiums, not automatically the entire payout. Article 1923 of the Civil Code protects the sums owed by the insurer, but preserves, with respect to the paid premiums, the rules on collation, imputation, and the reduction of donations. This rule prevents the insurance instrument from becoming, solely because of its form, a means to unlimitedly withdraw resources from the protection provided for certain heirs.
The practical consequence is significant: not every premium is included in the mass to be considered, nor must every beneficiary return what they received just because they do not coincide with the heirs. It must first be ascertained whether the payment of the premiums had, in the specific case, a gratuitous function: in simple terms, whether the policyholder used their own resources to confer a gratuitous advantage upon the beneficiary.
The evaluation does not depend on a single isolated figure. Weight is given to the total amount of the premiums, their impact on the policyholder's assets and income, the duration of the payments, the age and personal conditions of the person contracting the policy, the structure of the policy, and any financial interest of the beneficiary. A sustainable premium consistent with a welfare purpose does not present the same problem as payments that have absorbed a decisive part of the policyholder's availability in favor of a third party.
Collation concerns the rebalancing among certain co-heirs who have received gratuitous acts from the deceased; imputation serves to calculate how much a reserved heir has already received; reduction instead protects the reserved quota when donations or testamentary dispositions have compromised it. These are different remedies: they must not be used as synonyms and do not apply indiscriminately to all heirs.
The breach of reserved shares is not presumed: it must be calculated
Being a child or a spouse is not enough, on its own, to obtain a share of the policy. The breach of the reserved share exists only if, after the calculation required by law, the reserved quota proves to be actually insufficient. Reserved heirs include the spouse, children, and their descendants by representation; ascendants are relevant only if there are no children or other descendants.
The calculation starts from the assets remaining at the time of death, subtracts debts, and considers donations made during lifetime solely for the purpose of verifying the disposable quota and the reserved quota. This is the mechanism of the so-called fictitious reunion: it does not materially transfer all assets into the hereditary estate, but makes it possible to measure whether the gratuitous acts have exceeded the limit that the deceased could freely attribute.
In the case of the policy, the comparison cannot stop at the amount paid by the company. The special provision of Article 1923 requires focusing attention on premiums that may have a gratuitous nature. For this reason, a very high payout, accrued also thanks to the product's return, does not automatically equate to a donation of equal value made by the policyholder.
If the calculation shows a breach, the reserved heir can assess the action for reduction against the prejudicial attributions. The Ministry of Justice recalls that this action serves to reinstate the reserved quota by reducing testamentary dispositions and donations that have compromised it; the page on succession actions offers an institutional framework of the remedy. The claim requires a complete reconstruction of the assets, debts, gratuitous attributions, and the position of the acting party.
Insurance policy and investment: the product name does not decide
Not everything called a “life policy” performs the same function. Some products link the owed value to the return of funds or financial indices. In these formulas, often called unit-linked, the investment risk can weigh very differently on the policyholder, and the risk tied to human life may be actual, limited, or almost irrelevant.
The Court of Cassation has clarified that the contract must be interpreted beyond its commercial label. In particular, it distinguished formulas providing for a capital guarantee, total or partial, from those in which the owed sum depends exclusively on the value of the financial parameter and the investment risk remains entirely borne by the policyholder. The reference is found in the civil review by the Court of Cassation on order no. 9418 of April 9, 2024. The precedent concerned contracts predating the 2005–2006 reforms: applying its principle to a particular policy also requires consideration of the contract date and the relevant legal regime.
This distinction can change the legal classification of the matter. If the contract genuinely performs an insurance and welfare function, the special rules of Articles 1920 and 1923 of the Civil Code apply. If instead a financial investment devoid of insurance substance emerges, it is incorrect to apply those protections automatically simply because the word “policy” appears in the documents.
To navigate this, concrete clauses are needed: death guarantees, minimum capital measurements, fund links, risk of loss, surrender options, and performance calculation criteria. The contractual file matters more than the title reported in the bank statement or commercial communication.
What circumstances truly change the answer
The origin of the premiums is a first decisive fact. It is necessary to distinguish sums paid by the policyholder with their own resources from those deriving from money also belonging to another subject or already tied by a different relationship. The mere titling of the policy does not always resolve this question: bank movements and the origin of funds can clarify who economically supported the operation.
The timing of payment also matters. Periodic premiums of limited amounts paid over many years raise a different issue than a very high single premium arranged shortly before death. The temporal data does not prove on its own either a gratuitous act or a breach, but helps understand whether the payment was compatible with the declared economic function and residual assets.
The beneficiary's position deserves independent attention. Being an heir as well does not eliminate the problem, because the insurance benefit and the hereditary share have different titles. However, the status of spouse, child, co-heir, or third party affects the rules of collation, any imputation, and the type of protection concretely invocable.
How to address the problem without confusing remedies
The first alternative is to accept that the benefit belongs to the beneficiary. This is the consistent solution when the policy is genuinely an insurance contract, the designation is valid, and the premiums have not caused a breach of the reserved share. In this situation, it is incorrect to demand a hereditary division of the payout simply because the policyholder has passed away.
The second alternative is to verify the protection of the reserved share on the premiums. This path requires a patrimonial calculation based on concrete data and the distinction between premiums, the value of the insurance benefit, and other donations or dispositions of the deceased. Acting solely on the difference between heirs and beneficiaries can lead to a claim lacking the necessary foundation.
If the doubt concerns the nature of the product, the contract review must be addressed first. It is not useful to immediately discuss reduction if there is no certainty that it is a true life insurance. In an initial discussion, the complete policy, designation or revocation riders, periodic statements, company communications, payment extracts, and an overview of assets and debts existing at the date of death are normally useful.
Frequently Asked Questions
Can I claim a part of the policy if I am an heir but not a beneficiary?
Not automatically. The payout of a true life policy generally belongs to the designated beneficiary and does not enter the hereditary division. If you are a reserved heir, you can nevertheless verify whether the premiums paid by the deceased had a gratuitous nature and whether, together with other attributions, they breached your reserved share.
Must all policy premiums be returned to the succession?
No, there is no automatic return of all premiums. Their relevance depends on the function of the payment and the overall calculation of succession. The rule preserves the protection relating to collation, imputation, and reduction, but the applicable remedy changes based on the status of the heirs, the nature of the gratuitous act, and the actual breach.
Must the company pay the heirs if the beneficiary is an outside person?
The company must follow the effective designation. The fact that the beneficiary is not a family member or an heir does not invalidate the policy. Heirs may have a succession issue concerning the premiums only if the prerequisites exist to assert a breach of the reserved share or another remedy provided by law.
If the beneficiary renounces the inheritance, do they also lose the life policy?
Generally no: the right to the insurance payment is independent of the inheritance. Even a generic designation of “heirs” normally identifies beneficiaries through their entitlement to inherit, without requiring acceptance of the inheritance. This is explained by the Joint Divisions of the Court of Cassation, judgment no. 11421/2021. A different contractual intention must be unequivocal.
Is a unit-linked policy always a valid life policy for succession purposes?
No, the denomination is not decisive. It must be understood whether the company assumes a real insurance risk linked to human life or whether the result depends solely on the financial performance of the investment. Capital guarantees, death-case clauses, and the risk of loss are essential data to qualify the product.